Pesticide Exposure Could Increase Disease Risk For The Next 20 Generations

Health risks from synthetic chemicals in the environment may not end with the people directly exposed. Evidence suggests they can be recorded in the germline and persist across many generations.

Vinclozolin exposure during pregnancy and epigenetic transgenerational inheritance

A recent study reports that a one-off exposure to the fungicide vinclozolin during pregnancy raised the likelihood of illness for 20 generations of rats. More strikingly, the inherited health burden did not simply persist: the problems appeared to intensify as time went on, with disease outcomes becoming more severe in later generations.

Although the work was conducted in rodents, the researchers argue that such pronounced effects in a well-established mammalian model may carry important implications for humans.

Why epigenetics can pass risk through the germline

The phenomenon under investigation is epigenetic transgenerational inheritance. Rather than involving a DNA mutation, it arises when non-mutational shifts in how DNA is regulated occur in an organism’s germline-the cell lineage that ultimately produces sperm and egg cells-altering the way essential genes are expressed.

As earlier research has indicated, the inherited disease vulnerability passed down in this way can outweigh the danger faced by an individual who is only directly exposed to the chemical.

Michael Skinner, a biology professor at Washington State University and a co-author of the study, explains the chain of exposure in pregnancy in practical terms: when a pregnant female encounters a chemical, the developing foetus is exposed as well-and so are the germ cells forming inside that foetus. As a result, potential effects may be seen not only in the immediate offspring but also in subsequent generations. Once such a pattern is “programmed” into the germline, he suggests, it can remain as enduring as a genetic mutation.

Skinner first helped describe the epigenetic inheritance of disease risk around two decades ago and has continued to study the process since then.

From 10 generations to 20: what the rat lineage revealed

In a separate recent study, Skinner and colleagues followed rats for 10 generations after a single ancestral exposure to vinclozolin, a compound previously associated with potential health harms including endocrine disruption and cancer. They found that disease risk rose and remained elevated through all 10 generations-prompting questions about how long such effects might last and whether they could worsen.

For the new research, the team extended follow-up of that same rat lineage to 20 generations.

Across those generations, they observed a persistent pattern of disease affecting multiple organs, including the kidneys, prostate, testes, and ovaries, alongside other health impacts. While the overall presence of disease remained broadly steady at first, later generations showed a troubling shift: around the 15th generation the situation began to deteriorate, and by the 16th through 18th generations disease became far more pronounced. The researchers also reported birth-related abnormalities, with a rise in deaths among birthing mothers and/or their pups-described as a highly lethal pathology.

What this could mean for humans amid rising chronic disease

The researchers note that previous studies have identified epigenetic changes in human germlines that align with findings from mammalian models.

At the same time, rates of chronic disease in people are increasing. This rat research cannot prove a direct link in humans, but the timing is suggestive: the upward trends in chronic illness parallel the growing prevalence of pesticides and many other synthetic chemicals.

There is also a profound timescale difference. Whereas 20 rat generations can pass in only a few years, Skinner points out that 20 human generations could span roughly half a millennium. Even so, he remains hopeful that epigenetics will reveal practical ways for medicine to intervene.

Biomarkers and the shift from reactionary to preventative medicine

Skinner argues that the results underscore the need to address the problem rather than assume it will fade with time. In his view, epigenetics can help move healthcare away from reactionary treatment and towards preventative medicine.

He notes that researchers already have epigenetic biomarkers for around 10 different disease susceptibilities in humans. These markers do not indicate that a person has a disease at present; instead, they can suggest heightened odds of developing a condition decades later-such as 20 years into the future. That window, he says, could enable a range of preventative approaches taken before disease emerges, with the goal of delaying onset or preventing illness altogether.

Broader implications: regulation, exposure reduction, and research priorities

If epigenetic transgenerational inheritance proves to be a meaningful contributor to human disease, it strengthens the case for public-health decisions that account for long-term, population-level consequences-not only immediate toxicity. That could influence how pesticides and other industrial compounds are evaluated, particularly regarding exposure during pregnancy, when multiple generations may be biologically “in the line of fire”.

It also highlights the value of tracking real-world mixtures of chemicals, not just single compounds in isolation. People are typically exposed to complex combinations through food, water, household materials, and agricultural drift, so identifying which exposures most strongly affect the germline-and at what life stages-could become a key research and policy priority.

The study was published in the Proceedings of the National Academy of Sciences.